Myopia Management: Slowing Nearsightedness

Atropine is a medication traditionally used to dilate the pupil, but at very low concentrations (typically 0.01% to 0.05%), it has been shown to slow the elongation of the eye without causing significant side effects. Your child would use a single drop in each eye at bedtime. Studies have demonstrated that low-dose atropine can reduce myopia progression by roughly 50% in many patients, though individual results vary. The drops are generally well tolerated, with most children experiencing little to no pupil dilation or light sensitivity at the lowest concentrations.

Orthokeratology, commonly called ortho-K, involves wearing specially designed rigid gas-permeable contact lenses overnight. These lenses gently reshape the cornea (the clear front surface of the eye) while your child sleeps, providing clear vision throughout the day without the need for glasses or daytime contacts. Beyond the convenience factor, ortho-K has been shown in multiple clinical studies to slow axial eye growth, which is the primary driver of myopia progression. Proper lens hygiene and regular follow-up visits with our eye doctor are essential to ensure safe and effective use.

Certain soft contact lenses with a center-distance, peripheral-add design create a specific pattern of focus on the retina that signals the eye to slow its growth. These dual-focus or multifocal lenses are worn during the day like standard contacts and have been shown in clinical trials to reduce myopia progression by approximately 30% to 50%. They are a good option for children who are comfortable handling contact lenses and prefer daytime wear over overnight ortho-K.

Research consistently shows that spending more time outdoors is associated with a lower risk of developing myopia and may help slow its progression. Current recommendations suggest at least 90 to 120 minutes of outdoor time daily for children. Reducing prolonged, uninterrupted near work and taking regular visual breaks (following the 20-20-20 rule, which involves looking at something 20 feet away for 20 seconds every 20 minutes) can also support healthier visual development.

In cases where a single treatment does not adequately slow progression, our optometrist may recommend combining strategies. For example, low-dose atropine drops can be used alongside ortho-K or multifocal contact lenses for children with rapidly progressing myopia. This layered approach allows for a stronger treatment effect while carefully monitoring for any changes in response.

Side effects are generally mild. Low-dose atropine may cause slight light sensitivity or mild pupil dilation in some children, though these effects are minimal at the concentrations used for myopia control. Contact lens-based treatments carry the standard risks of any contact lens wear, including the small possibility of infection if hygiene instructions are not followed. Our optometrist reviews all potential risks with you before starting any treatment and provides clear care instructions.

Most children remain on a myopia management program until their late teens, when the rate of eye growth naturally begins to slow. The exact duration depends on when treatment starts, how quickly your child was progressing before intervention, and how the eyes respond over time. Stopping treatment too early can sometimes lead to a rebound in progression, so our eye doctor monitors carefully before making any changes.

Myopia management slows the worsening of nearsightedness but does not reverse myopia that has already developed. Your child will still need some form of vision correction, whether glasses, contact lenses, or the correction built into their management lenses. The goal is to keep the final prescription as low as possible rather than to eliminate the need for correction entirely.

Our optometrist tracks two key measurements at each follow-up visit: the refractive prescription and the axial length of the eye (the front-to-back measurement that indicates growth). A slowing in the rate of prescription change and reduced axial growth compared to the expected rate for your child's age are both strong indicators that the treatment is effective. Follow-up visits are typically scheduled every four to six months.

Coverage varies depending on your insurance plan. Some vision plans cover portions of specialty contact lens fittings or medically necessary treatments, while others may not. Low-dose atropine drops are often compounded by a specialty pharmacy and may not be covered under standard prescription drug plans. We recommend contacting your insurance provider to confirm your benefits, and our team can help provide any documentation needed for pre-authorization.